Tekla Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $41.8M | Buy |
343,695
+21,478
| +7% | +$2.61M | 1.63% | 17 |
|
|
2023
Q1 | $49.5M | Buy |
322,217
+57,290
| +22% | +$8.8M | 1.88% | 17 |
|
|
2022
Q4 | $47.6M | Sell |
264,927
-49,997
| -16% | -$8.98M | 1.8% | 18 |
|
|
2022
Q3 | $37.2M | Sell |
314,924
-13,600
| -4% | -$1.61M | 1.52% | 22 |
|
|
2022
Q2 | $46.9M | Hold |
328,524
| – | – | 1.84% | 17 |
|
|
2022
Q1 | $56.6M | Sell |
328,524
-218,100
| -40% | -$37.6M | 1.99% | 17 |
|
|
2021
Q4 | $139M | Buy |
546,624
+87,168
| +19% | +$22.1M | 4.47% | 2 |
|
|
2021
Q3 | $177M | Sell |
459,456
-6,321
| -1% | -$2.43M | 5.69% | 1 |
|
|
2021
Q2 | $109M | Sell |
465,777
-6,525
| -1% | -$1.53M | 3.56% | 4 |
|
|
2021
Q1 | $61.8M | Buy |
472,302
+224,110
| +90% | +$29.3M | 2.13% | 12 |
|
|
2020
Q4 | $25.9M | Sell |
248,192
-212,167
| -46% | -$22.2M | 0.91% | 32 |
|
|
2020
Q3 | $32.6M | Sell |
460,359
-32,147
| -7% | -$2.27M | 1.22% | 19 |
|
|
2020
Q2 | $31.6M | Buy |
492,506
+238,360
| +94% | +$15.3M | 1.2% | 21 |
|
|
2020
Q1 | $7.61M | Buy |
+254,146
| New | +$7.61M | 0.34% | 59 |
|